Carl D. Regillo

Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies

Steven D. Schwartz, Carl D. Regillo, Byron L. Lam et al. · The Lancet · 2014 · 1.3K citations

Macular Dystrophy, Developmental Biology, Retina +10

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

Carl D. Regillo, David M. Brown, Prema Abraham et al. · American Journal of Ophthalmology · 2008 · 859 citations

Ocular Disease, Ophthalmology, Experimental Ophthalmology +4

Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration

Allen C. Ho, Brandon Busbee, Carl D. Regillo et al. · Ophthalmology · 2014 · 577 citations

Genetic variants near <i>TIMP3</i> and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration

Wei Chen, Dwight Stambolian, Albert O. Edwards et al. · Proceedings of the National Academy of Sciences · 2010 · 511 citations · Full text

Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial

Lyndon da Cruz, Jessy D. Dorn, Mark S. Humayun et al. · Ophthalmology · 2016 · 344 citations · Full text